Φορτώνει......
Preclinical safety assessment of pathogen reduced red blood cells treated with amustaline and glutathione
BACKGROUND: The nucleic acid targeted pathogen reduction (PR) system utilizing amustaline (S‐303) and glutathione (GSH) is designed to inactivate blood‐borne pathogens and leukocytes in red blood cell concentrates (PR‐RBCC). Inactivation is attained after amustaline intercalates and forms covalent n...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Transfusion |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley & Sons, Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7027779/ https://ncbi.nlm.nih.gov/pubmed/31930533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15662 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|